When Antibiotics Are Not Enough: A Plain-English Guide to Body Reserve

A patient-friendly explanation of the ReBalU resistant-plague thought experiment. SOD Sciences, ReBalU Platform. Joseph M. Salvani and Daniel Walsh.

What this guide is. This guide explains a thought experiment: what would happen inside the body if the bacteria that cause plague ever became resistant to the medicines used against them? It takes a real news event as its starting point, then explains in everyday language how the body's own defense reserve works, and why scientists are studying whether it can be measured and strengthened.

This is research education, not medical advice. Nothing described here is a treatment for plague or any other infection, and you should always follow your doctor's guidance for any illness.

Why We Wrote This

In late September 2026, a 28-year-old scientist who worked at a plague research laboratory in Siberia suddenly became very ill with a lung infection and died a few days later. Authorities still do not know what caused her death. People who had been near her were checked and kept apart for a while, and none have been reported to have developed the illness. Health officials say the risk to the public is very low.

Her story made people ask an uncomfortable question. Plague still exists in the world. It lives in wild animals in some regions, including the very part of Siberia where that laboratory sits. We have medicines that cure it. But what if, one day, a version of the germ appeared that those medicines could not stop? That question is the reason for this guide.

The Scary Question, Answered Honestly

Plague is caused by a bacterium, a germ called Yersinia pestis. Today it is almost always curable with antibiotics when caught early. The what-if scenario is that the germ stops responding to those medicines.

That worry is not fantasy. In 1995, doctors in Madagascar found a strain of the plague germ that was resistant to several standard antibiotics at once, and the resistance was carried on a piece of shared genetic material that can move between bacteria. Years later, scientists confirmed that a resistant strain actually spread from person to person during an outbreak. So researchers take the possibility seriously, even though, in reality, plague today remains treatable in most cases.

Here is the important part for this guide. If antibiotics ever stopped being the deciding factor, the patient's own body would carry more of the burden. Not because drugs, hospital care and quarantine would stop mattering, because they would still matter enormously. But the differences between people, meaning how much damage their bodies can absorb, how well their immune systems behave, and how fast they recover, would matter more. Those differences are what our research measures. Scientists call it your body's reserve.

Your Body's Savings Account

Think of your body's antioxidant defenses as a savings account. Every day, your cells quietly build and spend a currency of protective molecules. One of the most important is called glutathione, one of the body's main recycling antioxidants. It soaks up the wear-and-tear chemicals that stress, inflammation and infection produce, then gets refreshed and used again.

When you are healthy and rested, the account has a healthy balance. When you are under long-term stress, dealing with ongoing illness, or simply born with less efficient versions of certain protective genes, the balance runs low. That balance is your reserve: your body's stored capacity to handle stress.

A few things set your starting balance. Some are genetic, meaning small, normal variations in the genes that build your antioxidant equipment. Some are lifestyle, meaning diet, sleep, chronic stress and gut health. The genes set the range of what is possible. Your daily biology decides where in that range you are actually running. That distinction becomes important later.

Three Ingredients That Refill the Account

The ReBalU research program studies whether three food-based ingredients, working together, can help the body refill its own reserve. None of them works by dumping antioxidants into the body from outside. They work by nudging the body to build more of its own defenses, a bit like retraining a factory to run a faster shift rather than shipping in products from elsewhere.

One. Tagatose, the food. Tagatose is a natural, low-calorie sweetener that tastes like sugar but behaves very differently in the body. Most of what you swallow is not absorbed. It travels down to the large intestine, where the helpful bacteria that live there ferment it. In other words, tagatose is food for your good gut bacteria, and what they produce from it is the next ingredient.

Two. Butyrate, the message. When those gut bacteria digest tagatose and certain fibers, they make small molecules called short-chain fatty acids. The best known is butyrate. Butyrate acts like a key that unlocks parts of the cell's instruction manual, the DNA. It loosens the packaging around certain genes so the cell can actually read them, including the genes for building antioxidant defenses. The body makes this message itself, at its own pace, from the food you eat.

Three. DHA from marine algae, the signal. DHA is the healthy omega-3 fat famous from fish, but here it comes from the algae the fish eat. DHA settles into the membranes that wrap every cell. As the body naturally processes some of it, it produces tiny byproduct molecules that act like a gentle poke to a master switch inside the cell, a switch scientists call Nrf2. When poked, the switch turns on a whole family of defense genes: more antioxidant building blocks, more cleanup enzymes, more of the machinery that keeps glutathione refreshed and ready.

Put simply. Tagatose feeds the gut bacteria. The bacteria produce butyrate, which unlocks the defense-gene instruction manual. Algae-derived DHA pokes the master switch that tells the cell to actually read it. Food, message, signal: three steps that end with your own cells building a bigger, better-refreshed reserve.

Better Brakes and Better Stamina

A stronger reserve is not just about armor. It is also about control and endurance, and this is where the story gets interesting for the immune system.

The brakes

Your immune system has a gas pedal and brakes. The gas pedal is inflammation, the attack response that fights invaders. The brakes are a special kind of white blood cell called regulatory T cells, or Tregs for short. Their job is to keep the attack pointed at the threat instead of at your own tissues.

Butyrate turns out to help the body produce and maintain these brakes. It does this in the gut first, where it helps new Tregs form, but those cells then travel through the bloodstream, patrolling the whole body. Smaller amounts of butyrate absorbed from the gut also carry a calmer signal to immune cells farther away. The result is better balance. The attack still happens, but it does less collateral damage to the house it is defending.

People with low reserve often have weak brakes to begin with. Their braking system exists but is under-supported. For them, restoring steady butyrate production does not create something foreign. It turns the brakes back up toward where they were designed to run. That is why the effect feels so large in exactly the people who started with the least.

The stamina

When your immune system spots a threat, defensive white blood cells multiply, sometimes doubling many times over. Each round of doubling costs energy and produces wear-and-tear chemicals, and a cell whose internal battery is drained can trigger its own early retirement instead of finishing the fight.

Research shows that the same master switch we mentioned, Nrf2, helps activated immune cells handle their energy supply and multiply more effectively, and that antioxidant enzymes protect memory immune cells from wearing out early. A refilled reserve gives immune cells the stamina to complete their expansion without burning out mid-fight.

What stronger than your genes really means. Your genes set the hardware, including the small, normal variations that make some people's antioxidant equipment more or less efficient at baseline. But the day-to-day setting of that equipment is biology, not destiny. The three ingredients push those settings toward the top of the range your own genome already allows. That means stronger than your body's usual, tired baseline, never stronger than your genes permit. The ceiling is fixed. The current setting is not.

Why Healthy and Sick Cells May Respond Differently

A laboratory finding, explained simply. The following comes from experiments on cancer cells in laboratories. It helps explain how the same ingredients can help healthy cells while harming sick ones. It has not been shown as an effect in patients, and its relevance to infections like plague is conceptual only.

Here is the puzzle. If butyrate and DHA raise antioxidant defenses, would that not protect every cell, including sick ones? In laboratory cancer-cell models, the answer turns out to be no, for two fascinating reasons.

Butyrate becomes a trap. Healthy cells burn butyrate cleanly as fuel. Many cancer cells have switched to a different, wasteful way of eating, the same sugar-burning style that makes tumors grow. Because of that switch, they cannot burn butyrate properly. It builds up inside them, and the same molecule that gently unlocked genes in healthy cells becomes, in the sick cell, a prolonged signal that stops growth and triggers a built-in clean self-removal program scientists call apoptosis, the cell's own version of a dignified exit.

DHA becomes too much of a good thing. Many sick cells naturally stuff their membranes with easily-oxidized fats, and it is part of what makes them fragile. Supply DHA, and they obligingly load it in. Then the wear-and-tear chemistry accumulates faster than their defenses can clear it. When that passes a threshold, iron-linked membrane damage, which scientists call ferroptosis, pushes the vulnerable cell to die. A healthy cell, with headroom in its defenses, simply clears the same damage and comes out stronger.

The takeaway is not that these ingredients fight disease. It is subtler. They restore the protection of cells that are working properly, while removing the hidden crutch that sick cells were leaning on. Whether this logic applies to infected or stressed cells during a real illness has not been shown. That is a question for research, not a promise.

What This Cannot Do

Honesty matters most in exactly this section. Plague moves frighteningly fast. Symptoms can appear within a day of exposure, and untreated lung plague can kill within a few days. The reserve-building approach described here works over weeks, not hours. So:

It cannot rescue an active, fast-moving infection. Food-based reserve building is slow. Acute infection care is fast. Different jobs entirely.

It is not a substitute for antibiotics, hospital care, quarantine or public-health measures. In the resistant scenario, those would remain the main battle plan.

Nothing in the ReBalU program is proven to prevent or treat plague or any other infection in people. Every mechanism in this guide is demonstrated in laboratory or animal studies, and the program's job is measurement and research.

This guide is not medical advice. For any illness, follow your clinician's guidance.

So what is the point of the thought experiment? It clarifies the real research question: if the medicine layer ever thinned, would people with wider measured reserve tolerate severe illness better than people with narrow reserve? ReBalU's test, treat and retest loop exists to ask that question honestly. Measure the reserve, use the food-based protocol, retest, and see whether the reserve actually widened. No more, no less.

The Bottom Line

Your body carries a savings account of protective capacity. Some people are born with a lower ceiling for it, everyone's balance drifts down under stress and illness, and the balance can move back up when the body's own defense-building machinery is properly fed and signaled. The ReBalU research program measures that account with a test, tries to refill it with three food-based ingredients that cooperate with the body rather than overriding it, and then measures again to see whether it worked.

The resistant-plague scenario is a stress test for that idea, a way of asking what the host side of a terrible infection would look like if the medicine side were weakened. It is not a prediction, and the Siberia case it was prompted by remains unsolved. But the question beneath it is universal: who tolerates severe illness better, and can the difference be measured and widened in advance? That is what our research is for.

Where This Comes From

The Siberia events are reported by major news organizations. The resistance history, the laboratory studies and the immune research are published in peer-reviewed journals. Key sources in plain language:

1. Reuters, news report on the Siberia laboratory worker's death and the public-health response.
2. AP News, plain-language facts about pneumonic plague and the WHO's risk assessment.
3. The New England Journal of Medicine, on the 1995 discovery of multidrug-resistant plague in Madagascar.
4. Clinical Infectious Diseases, confirming that a resistant plague strain spread during an actual outbreak.
5. PLOS Pathogens, on how the plague germ suppresses neutrophils, the immune system's front-line cells.
6. US Patent 7,202,219, tagatose as a prebiotic, meaning food that gut bacteria turn into butyrate.
7. JECFA, the UN and WHO food-safety experts, on how tagatose is digested and fermented in the body.
8. Journal of Neuroscience, on how DHA activates the cell's master antioxidant switch.
9. Peer-reviewed reviews in PMC, on butyrate as the gut's message, unlocking genes and supporting regulatory T cells.
10. PMC, on laboratory studies of DHA pushing cancer cells toward ferroptosis.
11. PMC, on the master switch Nrf2 helping immune cells expand with more stamina.

ReBalU Plague Host-Reserve Research, a patient-education companion to the Resistance Scenario mechanism annex. Prepared as research education, not medical advice. Hypothetical scenario analysis. No prevention, treatment or mitigation claims are made or implied for plague or any other infection.

This document presents a scientific hypothesis for discussion. The ReBalU protocol has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease, including plague. If you have symptoms of an infection, or believe you may have been exposed to one, seek medical evaluation without delay. Nothing here is a reason to delay, decline or stop taking antibiotics or any other care your doctor has recommended, and you should speak with your own physician before starting any supplement.